Product Images Tizanidine

Improvement in Ashworth Score after administration of 16 mg tizanidine compared to placebo. The evaluation was done at different hours post-dose.*

The text describes a study that evaluates the improvement in Ashworth Score using zanidine as a medication. The mean dose used in the study is 28.6 mg. The study follows participants for a duration of 7 weeks, with the endpoint being the end of the maintenance period at week 7. The last observation carried forward method is used for data analysis.*

This text appears to be the description of a medication called Tizanidine tablets. Each tablet contains 4.576 mg of Tizanidine Hydrochloride, which is equivalent to 4 mg of Tizanidine base. The medication may cause dizziness or drowsiness. It is recommended to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets should be dispensed in a container that is both tight and light-resistant, using a child-resistant closure. It is important to keep this medication and all drugs out of the reach of children. The National Drug Code (NDC) for this product is 71335-2325-1. The tablets are identified as "tiZANidine Tablets, USP" and come in a pack of 30 tablets. The tablets have been repackaged by Bryant Ranch Prepack, Inc. and are manufactured by Dr. Reddys Laboratories Ltd.*